Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology - United States
doi 10.1016/j.ajpath.2019.10.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer
Cancer ResearchOncology
2017English

Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Cancer
Cancer ResearchOncology
2011English

The Ratio of CD8 to Treg Tumor-Infiltrating Lymphocytes Is Associated With Response to Cisplatin-Based Neoadjuvant Chemotherapy in Patients With Muscle Invasive Urothelial Carcinoma of the Bladder

OncoImmunology
OncologyAllergyImmunology
2016English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2017English

Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer

Urology
Urology
2017English

Quality of Pathologic Response and Surgery Correlate With Survival for Patients With Completely Resected Bladder Cancer After Neoadjuvant Chemotherapy

Cancer
Cancer ResearchOncology
2009English

Pathologic Tumor Response to Neoadjuvant Chemotherapy in Gastroesophageal Cancer: What Does It Mean?

Translational Gastroenterology and Hepatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy